InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Scalzo Richard William, Autre. Director active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 34 reports have been published. Split: 0 buy · 21 sells. Total volume traded: €620k. History available since 20 September 2021. The latest transaction was disclosed on 11 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Scalzo Richard William
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
1,112 sharesOrdinary SharesSEC:0001628280-26-044890:0
14,422 sharesOrdinary SharesSEC:0001628280-25-057681:0
1,343 shares@ US$11.381.3% of flowCommon StockSEC:0000950170-25-038731:0
917 shares@ US$11.831.0% of flowCommon StockSEC:0000950170-25-035490:0
2,488 shares@ US$13.953.1% of flowCommon StockSEC:0000950170-25-022455:0
1,455 shares@ US$28.123.7% of flowCommon StockSEC:0000950170-24-135570:0
32,700 shares0Common StockSEC:0000950170-24-134075:0
2,735 shares@ US$28.207.0% of flowCommon StockSEC:0000950170-24-127992:0
1,390 shares@ US$34.554.1% of flowCommon StockSEC:0000950170-24-108153:0
1,468 shares@ US$31.894.0% of flowCommon StockSEC:0000950170-24-105515:0
6,502 shares@ US$5.543.1% of flowCommon StockSEC:0000950170-24-105123:0
2,442 shares@ US$45.019.4% of flowCommon StockSEC:0000950170-24-099128:0
1,590 shares@ US$30.234.2% of flowCommon StockSEC:0000950170-24-072140:0
2,126 shares@ US$28.205.2% of flowCommon StockSEC:0000950170-24-062077:0
68,919 shares@ US$5.5433.2% of flowCommon StockSEC:0000950170-24-030482:0
2,273 shares@ US$25.855.1% of flowCommon StockSEC:0000950170-24-029603:0
3,429 shares@ US$1.030.3% of flowCommon StockSEC:0000950170-24-024298:0
13,000 shares@ US$1.031.2% of flowCommon StockSEC:0000950170-24-008061:0
13,000 shares@ US$1.031.2% of flowCommon StockSEC:0000950170-24-002277:0
2,376 shares@ US$12.022.5% of flowCommon StockSEC:0001209191-23-058666:0
1,380 shares@ US$10.721.3% of flowCommon StockSEC:0001209191-23-058332:0
681 shares@ US$12.010.7% of flowCommon StockSEC:0001209191-23-057671:0
89,742 shares0Common StockSEC:0001209191-23-055533:0
1,290 shares@ US$9.4113.0% of flowCommon StockSEC:0001209191-23-050174:0
1,397 shares@ US$10.411.3% of flowCommon StockSEC:0001209191-23-049361:0
25 of 34 declarations
About Scalzo Richard William
Scalzo Richard William is Autre, and is listed as SVP, Head of Finance & Admin. at Dyne Therapeutics, Inc. and Chief Financial Officer at CRESCENT BIOPHARMA, INC.. The declarant has 34 filings in total, and, across the recent sampled filings between 2021-09-22 and 2026-06-23, the transactions are mainly disposals for a total of EUR 637770, including amounts of EUR 348681.4799356083 on 2024-03-12, EUR 99142.80544538824 on 2024-08-20, and EUR 73218.97187095207 on 2024-11-18.
